MarketPeel
Pricing
…
President/CEO
Oren Gilad
Thu, Mar 12, 2026
Mar 12
received an award in APRE
20,175 shares @ $0.00
Increased holdings by +5.40%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APREAprea Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W-5.88%
1M+1.27%
3M—
6M—
1Y—

Recent insider activity at APRE

Jan 30Oren GiladBought$25.01kJan 30John P. HamillBought$5.07kDec 10John P. HamillBought$5.83kDec 10Marc DueyBought$25.00kApr 3Oren GiladBought$4.49kApr 3Oren GiladBought$5.62kOct 23Oren GiladBought$1.96kOct 18Marc DueySold$29.58k
Full APRE profile →Oren Gilad’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback